Last $0.0031 USD
Change Today -0.0001 / -3.12%
Volume 8.3M
BMSN On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

bio-matrix scientific group (BMSN) Key Developments

Bio-Matrix Scientific Group, Inc. announced delayed annual 10-K filing

On 12/30/2013, Bio-Matrix Scientific Group, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.

Bio-Matrix Scientific Group, Inc. announced delayed 10-Q filing

On 05/14/2013, Bio-Matrix Scientific Group, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

Entest Biomedical, Inc. and Bio-Matrix Scientific Group, Inc. Enter into Settlement Agreement with 18KT.TV LLC

On February 3, 2011, a complaint was filed in the U.S. District Court Middle District of the State of Pennsylvania against Entest Biomedical, Inc., David Koos (the company’s Chairman and CEO) and Bio-Matrix Scientific Group, Inc. by 18KT.TV LLC (Plaintiffs) seeking to recover general damages from the company in excess of $125,000. The complaint alleged breach of contract and unjust enrichment relating to an investor relations contract executed by the company and Craig Fischer (on behalf of 18KT.TV LLC). On March 1, 2013 a settlement agreement and mutual general release was entered into by and between the plaintiffs and the company. Pursuant to the agreement: The plaintiffs irrevocably release and forever unconditionally discharge the company of and from any and all actions, causes of action, suits, claims, debts, dues, accounts, bonds, covenants, charges, complaints, contracts, agreements, promises, judgments and demands whatsoever, in law or in equity. The company irrevocably releases and forever unconditionally discharges the plaintiffs  of and from any and all actions, causes of action, suits, claims, debts, dues, accounts, bonds, covenants, charges, complaints, contracts, agreements, promises, judgments and demands whatsoever, in law or in equity. The company shall cause to be issued to 18KT.TV LLC 41,000,000 of the company’s newly issued restricted common shares.

Entest Biomedical Mulls Acquisitions

Entest Biomedical, Inc. subsidiary of Bio-Matrix Scientific Group, Inc. is seeking acquisitions. Entest Biomedical focuses on developing and commercializing therapies, medical devices, and medical testing procedures for the veterinary market, as well as on acquiring and operating veterinary clinics.

Bio-Matrix Scientific Group, Inc. announced delayed annual 10-K filing

On 12/31/2012, Bio-Matrix Scientific Group, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BMSN:US $0.00 USD -0.0001

BMSN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BMSN.
View Industry Companies
 

Industry Analysis

BMSN

Industry Average

Valuation BMSN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIO-MATRIX SCIENTIFIC GROUP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.